There's enough funds to see their pipeline through to Ph2 but if IMU are going alone to Ph3 then they will need a lot of funds. By then, the pps will be worth a lot more as this is when BP offers premium price when IP have completed Ph2 clinical trial since they will have enough data to demonstrate efficacy.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-53
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.004(6.78%) |
Mkt cap ! $402.5M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.1¢ | 5.5¢ | $2.515M | 44.29M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 819340 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 515951 | 4 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |